Your browser doesn't support javascript.
loading
Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer setting.
Postmus, Douwe; Litiere, Saskia; Bogaerts, Jan; Versluis, Jurjen; Cornelissen, Jan J; Pignatti, Francesco.
Afiliación
  • Postmus D; European Medicines Agency, Amsterdam, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Litiere S; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Bogaerts J; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Versluis J; Erasmus Medical Center Cancer Institute, Department of Hematology, Rotterdam, the Netherlands.
  • Cornelissen JJ; European Medicines Agency, Amsterdam, the Netherlands; Erasmus Medical Center Cancer Institute, Department of Hematology, Rotterdam, the Netherlands.
  • Pignatti F; European Medicines Agency, Amsterdam, the Netherlands. Electronic address: francesco.pignatti@ema.europa.eu.
Eur J Cancer ; 197: 113496, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38134481
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido